181 related articles for article (PubMed ID: 29263184)
1.
Varga MG; Wang T; Cai H; Xiang YB; Gao YT; Ji BT; Pawlita M; Waterboer T; Zheng W; Shu XO; Epplein M
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):342-344. PubMed ID: 29263184
[No Abstract] [Full Text] [Related]
2. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
Wang T; Cai H; Zheng W; Michel A; Pawlita M; Milne G; Xiang YB; Gao YT; Li HL; Rothman N; Lan Q; Shu XO; Epplein M
Clin Infect Dis; 2017 May; 64(10):1380-1386. PubMed ID: 28402440
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
[TBL] [Abstract][Full Text] [Related]
7. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
8. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
[TBL] [Abstract][Full Text] [Related]
10. The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies.
Jang J; Wang T; Cai H; Ye F; Murphy G; Shimazu T; Taylor PR; Qiao YL; Yoo KY; Jee SH; Kim J; Chen SC; Abnet CC; Tsugane S; Zheng W; Shu XO; Pawlita M; Park SK; Epplein M
Int J Cancer; 2020 Aug; 147(3):777-784. PubMed ID: 31745972
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
[TBL] [Abstract][Full Text] [Related]
12. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
[TBL] [Abstract][Full Text] [Related]
13. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
14. Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer.
Camargo MC; Beltran M; Conde-Glez CJ; Harris PR; Michel A; Waterboer T; Carolina Flórez A; Torres J; Ferreccio C; Sampson JN; Pawlita M; Rabkin CS
Int J Cancer; 2015 Dec; 137(12):3000-5. PubMed ID: 26178251
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
[TBL] [Abstract][Full Text] [Related]
16. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.
Yamaoka Y; Kodama T; Kashima K; Graham DY
J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182
[TBL] [Abstract][Full Text] [Related]
17. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort.
Yuan JM; Yu MC; Xu WW; Cockburn M; Gao YT; Ross RK
Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):621-4. PubMed ID: 10428200
[TBL] [Abstract][Full Text] [Related]
19. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
20. Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method.
Shafaie E; Saberi S; Esmaeili M; Karimi Z; Najafi S; Tashakoripoor M; Abdirad A; Hosseini ME; Mohagheghi MA; Khalaj V; Mohammadi M
Microb Pathog; 2018 Jun; 119():137-144. PubMed ID: 29665437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
